6 agos 2020 año - RCT - HCQ as Postexposure Prophylaxis for Covid-19

Descripción:

These are just the highlights. I encourage you to read the article.

Randomized Controlled Trial:
"We enrolled adults who had household or occupational exposure..."

"...we randomly assigned participants to receive either placebo or hydroxychloroquine"

"After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure." [23]

Añadido al timeline:

fecha: